Initial Management of Functional Constipation in Adults
Start with polyethylene glycol (PEG) as first-line pharmacological therapy for functional constipation in adults without alarm features, after implementing basic lifestyle modifications including increased fluid intake, dietary fiber, and exercise. 1
Stepwise Treatment Algorithm
Step 1: Non-Pharmacological Foundation
Begin with lifestyle interventions that should be implemented immediately:
- Increase fluid intake to adequate hydration levels
- Increase dietary fiber through diet or supplementation
- Regular exercise and physical activity
- Establish regular bowel habits with adequate time for defecation 1
These non-pharmacological measures represent the initial management step, though they often require pharmacological augmentation for symptom control.
Step 2: First-Line Pharmacological Treatment
Polyethylene glycol (PEG) receives a strong recommendation as the preferred first-line agent 1, 2. This osmotic laxative has:
- The strongest evidence base among over-the-counter options
- Excellent safety profile
- Predictable efficacy
- Low cost and wide availability
Clinical pearl: PEG is superior to fiber supplementation for most patients and should be your go-to initial pharmacological choice.
Step 3: Second-Line Options if PEG Fails
If PEG is ineffective or not tolerated, the 2023 AGA-ACG guidelines provide strong recommendations for several alternatives 1:
Over-the-counter options:
- Sodium picosulfate (stimulant laxative) - strong recommendation
- Senna - conditional recommendation
- Magnesium oxide - conditional recommendation
Prescription options with strong recommendations:
- Linaclotide (secretagogue)
- Plecanatide (secretagogue)
- Prucalopride (serotonin type 4 agonist)
Step 4: Conditional Recommendations
The following have conditional recommendations (weaker evidence or more limited benefit-risk profile) 1:
- Fiber supplementation (psyllium specifically has better evidence than other fibers)
- Lactulose (osmotic laxative)
- Lubiprostone (secretagogue)
Strength of Evidence Hierarchy
The 2023 AGA-ACG guideline clearly stratifies recommendations:
Strong recommendations (use these preferentially):
- Polyethylene glycol
- Sodium picosulfate
- Linaclotide
- Plecanatide
- Prucalopride
Conditional recommendations (consider as alternatives):
- Fiber
- Lactulose
- Senna
- Magnesium oxide
- Lubiprostone
Important Clinical Considerations
Cost and access matter: While prescription secretagogues (linaclotide, plecanatide) and prucalopride have strong recommendations, PEG remains the most cost-effective first-line choice. Reserve prescription agents for patients who fail OTC therapies 1.
Avoid common pitfalls:
- Don't start with fiber alone—it has only conditional recommendation and may worsen symptoms in some patients
- Don't delay pharmacological treatment waiting for lifestyle changes alone to work
- Don't assume all laxatives are equal—PEG has the strongest evidence base
- Don't overlook that bisacodyl, despite being commonly used, was not included in the strong recommendation tier
When to escalate: If a patient fails first-line PEG therapy, move directly to either prescription secretagogues or prucalopride rather than cycling through multiple OTC options indefinitely 1, 3.
Special consideration for defecatory disorders: If you suspect pelvic floor dysfunction or dyssynergic defecation (symptoms of straining, incomplete evacuation, need for digital maneuvers), physiological testing and biofeedback therapy should be considered rather than escalating laxatives 4, 5.
Practical Implementation
Start here: PEG 17 grams daily, titrate based on response. This is your evidence-based starting point for pharmacological management 1.
If inadequate response after 2-4 weeks: Add or switch to sodium picosulfate or consider prescription secretagogues (linaclotide 145-290 mcg daily or plecanatide 3 mg daily) 1.
For refractory cases: Prucalopride 2 mg daily is specifically indicated for patients who have failed conventional laxatives 1, 3.